Obstetric Sleep Apnea Syndrome (OSA in Pregnancy)

A Complete Simplified Guide - From Standard ENT & Medical Textbooks + Recent Published Literature

1. What Is It? - Basic Definition

• Cummings Otolaryngology Head and Neck Surgery, p. 305
• Fishman's Pulmonary Diseases and Disorders, p. 1707

2. How Common Is It? (Epidemiology)

• Snoring occurs in roughly 35% of all pregnant women - which is a key early sign.
• Objectively diagnosed OSA (proven on sleep study) affects 4% to 9% of all pregnant women in the United States (based on multicenter data), even in low-risk pregnancies.
• In pregnancies with obesity, gestational diabetes, hypertension, or other complications, the prevalence is much higher.
• In large population databases using diagnostic codes, the reported prevalence is only 0.1% - this grossly underestimates the real problem and means OSA in pregnancy is heavily underdiagnosed.
• About 50% of women diagnosed with OSA in pregnancy will still have it after delivery (postpartum).

These numbers come from the Fishman's Pulmonary Diseases and Disorders pregnancy chapter and are supported by the 2023 CPAP systematic review (Nugent et al., PMID: 36866618).

3. Why Does Pregnancy Cause or Worsen OSA? (Pathophysiology)

A. Anatomical / Structural Changes

B. Respiratory / Physiological Changes

• Reduced FRC (Functional Residual Capacity): Less air in the lungs at rest means the airways lose their internal "stiffening" support. This makes the throat more prone to collapse during breathing.
• Progesterone effect (double-edged): Progesterone is a respiratory stimulant - it increases breathing drive and strengthens upper airway dilator muscles. But it also increases the force of each breath (more negative inspiratory pressure), which creates a "suction" or vacuum effect on the already-narrowed airway - pulling the walls inward.
• Reduced REM sleep: Less deep sleep may reduce the frequency of apneas (protective), but overall sleep architecture is disrupted.

C. Protective Factors (Why Not Every Pregnant Woman Gets OSA)

• Progesterone strengthens the genioglossus (tongue muscle) and other dilators
• Lateral sleeping position in late pregnancy naturally helps keep the airway open
• Increased ventilation

• Fishman's Pulmonary Diseases, p. 1707; Murray & Nadel's Respiratory Medicine, p. 3031

1. Narrow/collapsible anatomy - worsened by pregnancy weight gain and edema
2. Low arousal threshold - the brain fails to wake up and reopen the airway
3. Weak upper airway dilator muscle response during sleep
4. High loop gain - unstable breathing control (overreaction to CO2 changes)

4. Sites of Obstruction (ENT Perspective)

• Type I (Retropalatal): Collapse behind the soft palate only
• Type II (Retropalatal + Retrolingual): Collapse behind both the palate AND the base of tongue
• Type III (Retrolingual): Collapse only behind the base of tongue

5. Signs and Symptoms (Clinical Presentation)

Nighttime Symptoms:

• Loud snoring (most common - affects ~35% of pregnant women)
• Witnessed apneas (partner notices breathing stops)
• Gasping, choking, or breath-holding during sleep
• Restless sleep
• Nocturnal sweating
• Morning and nocturnal headaches

Daytime Symptoms:

• Excessive daytime sleepiness (EDS) - but this is common in pregnancy generally, so it can mislead
• Morning fatigue or feeling "unrefreshed" regardless of sleep duration
• Memory problems, difficulty concentrating
• Depression, mood changes, irritability
• Morning sore throat

Important: Daytime sleepiness is hard to use as a diagnostic clue in pregnancy because it is normal. The Epworth Sleepiness Scale scores are NOT predictive of OSA in pregnant women, unlike the general population.

6. Complications - Why It Matters

Maternal Complications:

Fetal / Neonatal Complications:

• Intermittent hypoxia - oxygen levels drop repeatedly during apneas, reducing oxygen delivery to the placenta and fetus
• Oxidative stress - repeated hypoxia-reoxygenation causes free radical damage
• Systemic inflammation - raised inflammatory markers (IL-6, TNF-alpha, CRP)
• Sympathetic nervous system overactivation - raises blood pressure
• Endothelial dysfunction - damages the inner lining of blood vessels, contributing to pre-eclampsia
• Impaired placentation - possible disruption of normal placental blood flow (uterine artery Doppler changes seen in one large study per the 2025 systematic review, PMID: 39815441)

7. Severity Classification

8. Diagnosis

Step 1 - Screening

• Berlin Questionnaire: Poor positive and negative predictive values in pregnancy
• Epworth Sleepiness Scale (ESS): Not predictive of OSA in pregnant women
• STOP-BANG questionnaire: Used but not validated for pregnancy

• Chronic hypertension
• Older age
• Obesity (BMI ≥30)
• Snoring (especially habitual, loud snoring)
• Witnessed apneas

Step 2 - Objective Diagnosis

1. In-laboratory Polysomnography (PSG) - the gold standard. Records brain waves, oxygen levels, breathing effort, airflow, leg movements, and heart rate simultaneously during full sleep. A PSG is needed to definitively diagnose OSA.
2. Home Sleep Apnea Test (HSAT) - a simplified portable monitor worn at home. Records airflow, oxygen saturation, and respiratory effort. Less comprehensive than PSG but more convenient.

• AHI ≥ 5 events/hour with symptoms (sleepiness, choking, witnessed apneas) or comorbidities, OR
• AHI ≥ 15 events/hour regardless of symptoms

Step 3 - Site of Obstruction (ENT Specific)

• Fiberoptic nasopharyngoscopy - awake examination to assess nasal cavity, nasopharynx, oropharynx, hypopharynx, and larynx
• Müller maneuver - patient forcefully inhales against a closed mouth and nose while the surgeon watches through a fiberoptic scope to see where the airway collapses. Better for detecting retropalatal (palate-level) collapse, less useful for multilevel obstruction.
• Drug-Induced Sleep Endoscopy (DISE) - the patient is sedated with propofol/midazolam and the surgeon watches the airway collapse during pharmacologic sleep. More accurately reflects what happens during natural sleep. One meta-analysis showed DISE changed the surgical plan in >50% of cases. Not used in pregnancy due to medication safety concerns.

9. Treatment - Complete Overview

9A. Conservative / Lifestyle Measures

1. Positional therapy: Sleeping on the side (left lateral decubitus position) rather than the back. Supine sleeping worsens OSA because the tongue and soft palate fall backward. This is already recommended in late pregnancy for other obstetric reasons - so it carries a double benefit.
2. Weight management: While significant weight loss is not appropriate during pregnancy, avoiding excessive gestational weight gain reduces airway crowding.
3. Avoid alcohol and sedatives: Both relax pharyngeal muscles and worsen apneas. This is already contraindicated in pregnancy, providing additional benefit.
4. Smoking cessation: Smoking causes upper airway inflammation and mucosal edema. Avoiding it improves airway health.
5. Nasal decongestants/saline nasal spray: Helps with pregnancy-related nasal congestion, reducing nasal obstruction as a contributing factor. Topical saline is entirely safe in pregnancy.

9B. CPAP - The Primary Treatment (Most Important)

• 2023 Systematic Review (Nugent et al., PMID: 36866618, Australian & NZ Journal of Obstetrics and Gynaecology): CPAP treatment in pregnancy is well-tolerated with reasonable adherence. It appears to reduce blood pressure and pre-eclampsia, increase birth weight, and possibly reduce preterm birth.
• 2026 Meta-Analysis (Cabral et al., PMID: 40815548, The Laryngoscope - published just months ago): 7 studies, 696 pregnant patients. PAP therapy significantly lowered fasting plasma glucose (mean difference -6.50, p=0.002) and improved insulin resistance (HOMA-IR reduction). This shows PAP therapy specifically benefits glucose metabolism in high-risk pregnant women with OSA - a major finding given the link between OSA and gestational diabetes.

• In women with pre-eclampsia: small randomized trials showed that even one night of in-laboratory PAP therapy significantly improved hemodynamics (blood pressure, cardiac output) and reduced uric acid. This is a strong argument for treating OSA aggressively in pre-eclamptic patients.
• Auto-PAP (APAP): Because airway anatomy changes as pregnancy progresses (increasing edema and weight), the required CPAP pressure may increase. Standard fixed-pressure CPAP may need re-titration mid-pregnancy. Auto-PAP automatically adjusts pressure throughout the night to match changing needs - this is a practical advantage during pregnancy, avoiding the need for repeat sleep lab visits.
• Re-titration: CPAP should be re-titrated mid-pregnancy if symptoms worsen, or APAP should be used.

9C. Oral Appliance Therapy (Mandibular Advancement Device - MAD)

• Custom-fitted dental devices that advance the lower jaw (mandible) and tongue forward during sleep, enlarging the pharyngeal airway.
• Effective for mild to moderate OSA and patients who cannot tolerate CPAP.
• Adherence rates reported up to 77% (higher than CPAP).
• A crossover study (Ferguson et al.) showed oral appliances effective for AHI 15-50 with greater patient satisfaction than CPAP, though CPAP reduces AHI more effectively.
• Complications: tooth/jaw pain, difficulty chewing in the morning, excess salivation.
• In pregnancy: generally safe if the MAD was already being used. Starting a new MAD requires dental fitting - feasible but less commonly done in pregnancy.
• Recommended as second-line therapy for mild-to-moderate OSA by the European Respiratory Society (ERS).
• A follow-up sleep study with the device in place is recommended to confirm effectiveness.

9D. Nasal Therapies

• Nasal dilator strips (e.g., Breathe Right): Reduce snoring, mouth breathing, and nasal obstruction but do NOT effectively treat OSA as a standalone therapy.
• Intranasal corticosteroids (e.g., fluticasone): Useful when OSA coexists with allergic rhinitis or nasal inflammation. Shown to reduce AHI from 30.3 to 23.3 in one study. Intranasal fluticasone is generally considered safe in pregnancy (Category B/C - risk-benefit assessment required).
• Oxymetazoline nasal spray: Can reduce nasal congestion acutely but regular use is not recommended during pregnancy.
• Saline nasal irrigation: Safe and helpful for nasal congestion in pregnancy.

9E. Pharmacological Therapy

• In non-pregnant adults, Modafinil is FDA-approved to treat residual daytime sleepiness in OSA patients who use CPAP but still feel sleepy. It promotes alertness through α1-adrenergic stimulation. However, it is NOT used as primary treatment for OSA and is NOT recommended in pregnancy (safety data insufficient).
• Leukotriene receptor antagonists (e.g., montelukast): Shown promise in children by reducing adenoid size. Limited role in adults. Caution in pregnancy.
• Drug therapy is generally NOT recommended as primary treatment for OSA regardless of pregnancy status.

9F. Surgical Treatment (Not During Pregnancy - Elective, Deferred)

• Septoplasty, turbinate reduction - addresses nasal obstruction
• Reduces snoring and improves CPAP tolerance

• Uvulopalatopharyngoplasty (UPPP): Removes excess tissue from the soft palate and uvula. Success rate ~40-70%. The classic surgical option for retropalatal obstruction.
• Laser-assisted uvulopalatoplasty (LAUP): Less tissue removal, done under local anesthesia.
• Radiofrequency tissue ablation (Somnoplasty): Low-energy radiofrequency causes shrinkage of palatal or tongue base tissue. Multiple sessions needed.

• Genioglossus advancement: Moves the tongue's attachment point on the chin forward, tensioning the tongue and preventing backward collapse.
• Hyoid suspension: Attaches the hyoid bone to the mandible, enlarging the hypopharyngeal airway.
• Tongue base reduction (coblation, laser, radiofrequency)

• Palatal implants (Pillar Procedure): Three tiny polyester rods inserted into the soft palate to stiffen it and reduce vibration.
• Transpalatal advancement pharyngoplasty

• Robot-assisted tongue base resection and epiglottectomy/epiglottopexy.
• A multiinstitutional study (293 patients) showed mean AHI decrease of 24 with 20.7% complication rate.
• A systematic review of 16 studies showed robotic surgery as part of multilevel sleep surgery achieves "success" (AHI <20, 50% reduction).
• Best results when BMI <30.
• Increasing acceptance for tongue base OSA.

10. Recent and Emerging Treatment Modalities

A. Hypoglossal Nerve Stimulation (Upper Airway Stimulation - UAS)

• A device (Inspire system, FDA approved) is surgically implanted under the chest skin.
• It senses each breath and delivers a gentle electrical pulse to the hypoglossal nerve (the nerve controlling the tongue), causing the tongue to move forward and open the airway.
• The patient activates it with a small remote before sleeping.
• A 2024 systematic review (PMID: 38994886, The Laryngoscope) evaluated outcomes across multiple prospective studies - showed significant AHI reduction and improved quality of life.
• A 2023 comparative study (PMID: 35779166) found hypoglossal nerve stimulation comparable or superior to CPAP in CPAP-intolerant patients.
• Who qualifies: OSA patients who fail or cannot tolerate CPAP, without complete concentric collapse of the palate on DISE (must have good tongue-level collapse pattern). BMI typically <35.
• Not contraindicated post-pregnancy - an option for women who continue to have OSA after delivery.

B. External Hypoglossal Nerve Stimulation (Non-surgical)

• A newer, non-invasive version using an external stimulator placed under the chin to electrically stimulate the tongue during sleep.
• Mentioned in the 2025 Tang et al. review (PMID: 40753390) as a potential alternative to CPAP, including in pregnancy-related hypertensive disorders.
• Still largely investigational but promising as a non-surgical option.

C. Throat/Pharyngeal Muscle Training Exercises (Myofunctional Therapy)

• Exercises targeting the tongue, palate, pharynx, and facial muscles.
• Strengthen the upper airway dilators, reducing collapsibility.
• Studies show a reduction in AHI of ~50% and significant reduction in snoring severity.
• Safe during pregnancy - no pharmacological risk. Mentioned by Tang et al. (2025) as a potential non-pharmacological alternative.
• Includes: tongue-sliding exercises, tongue-pressing to roof of mouth, soft palate exercises, singing exercises.

D. Auto-PAP (APAP) and BiPAP in Pregnancy

• APAP - automatically titrates pressure breath-by-breath. Particularly valuable in pregnancy because the required pressure increases as the pregnancy advances. Eliminates the need for repeat formal titration studies.
• BiPAP (bilevel PAP) - provides different pressures for inhalation and exhalation. Used for more severe OSA or when regular CPAP is not tolerated. Can also support breathing in women with obesity hypoventilation.

E. Drug-Induced Sleep Endoscopy (DISE) - Advanced Diagnostic Tool

• Guides surgical planning by directly visualizing collapse during sedated sleep.
• Changed surgical plans in >50% of cases in meta-analysis.
• Not used in pregnancy (due to sedation requirements), but guides post-delivery surgical planning.
• Uses VOTE classification to document collapse: Velum (soft palate), Oropharynx, Tongue base, Epiglottis.

11. Labor and Delivery Considerations (Obstetric-ENT Intersection)

1. Airway management: Anesthesiologists must be informed. Pregnant women already have more difficult airways (edema, higher Mallampati score, reduced FRC). OSA makes this more challenging - increased risk of difficult intubation.
2. Opioid use caution: Opioids given for labor analgesia or post-cesarean pain relief can worsen OSA by causing respiratory depression and increasing upper airway collapsibility. Minimizing opioid use and preferring regional anesthesia (epidural) is preferred.
3. Magnesium sulfate: Commonly given for seizure prevention in pre-eclampsia. It relaxes muscles - including respiratory muscles - and may worsen airway collapse and apnea. Monitor closely.
4. Postoperative monitoring: Women with known OSA who undergo cesarean section need careful postoperative respiratory monitoring. CPAP should be available and used in the recovery room.
5. Bed positioning: Avoid prolonged supine positioning during labor and recovery.

12. Postpartum Period

• OSA generally improves postpartum as edema resolves and weight decreases.
• However, 50% of women with OSA diagnosed in pregnancy continue to have elevated AHI postpartum - meaning many women have underlying OSA that predated pregnancy and was unmasked or worsened by it.
• Post-delivery, formal reassessment with repeat sleep study is recommended.
• Surgical options (UPPP, hypoglossal nerve stimulation, DISE-guided surgery) can be considered after delivery once breastfeeding considerations and recovery are complete.

13. Preconception Counseling

• OSA may worsen during pregnancy
• Weight optimization before pregnancy reduces risk
• CPAP can be continued safely throughout pregnancy
• Sleep apnea increases risks of gestational hypertension, pre-eclampsia, and diabetes
• Obstetric team should be made aware of the diagnosis

14. Key Clinical Takeaways (Summary Table)

Sources Used

• Cummings Otolaryngology Head and Neck Surgery (standard ENT reference), Chapter 15 (Sleep-Disordered Breathing), pp. 305-316
• Fishman's Pulmonary Diseases and Disorders, Chapter on Sleep-Disordered Breathing and Pregnancy, pp. 1707-1708
• Murray & Nadel's Textbook of Respiratory Medicine, OSA in Pregnancy section, p. 3031

• Cabral et al. 2026 - PAP therapy in high-risk pregnancy: Meta-Analysis (The Laryngoscope, PMID: 40815548) - 2026 meta-analysis showing PAP improves glucose and insulin resistance
• Ansari, Bourjeily et al. 2025 - Emerging insights in maternal/fetal outcomes (Current Opinion in Pulmonary Medicine, PMID: 40916951)
• Tang et al. 2025 - OSA and hypertensive disorders in pregnancy (Reproductive Biology & Endocrinology, PMID: 40753390) - includes throat exercises and external hypoglossal stimulation
• La Verde et al. 2025 - OSA effect on feto-placental Doppler (Journal of Sleep Research, PMID: 39815441) - systematic review of placental blood flow changes
• Maniaci et al. 2024 - Comprehensive review of maternal and fetal implications (Neurology International, PMID: 38804478)
• Nugent et al. 2023 - CPAP effectiveness in pregnancy: Systematic Review (ANZ Journal of Obstetrics & Gynaecology, PMID: 36866618)
• Di Bari et al. 2024 - DISE impact on surgical outcomes (Sleep & Breathing, PMID: 37851322)
• Wesson et al. 2024 - Neurostimulation (hypoglossal) for OSA (The Laryngoscope, PMID: 38994886)

Obstructive Sleep Apnea Syndrome (OSAS)

Complete Exam-Ready Answer - From Cummings Otolaryngology (Standard ENT Textbook)

EXAM-READY DEFINITION (Write This in Exams)

Obstructive Sleep Apnea Syndrome (OSAS) is a sleep disorder characterized by repeated episodes of partial or complete collapse of the pharyngeal airway during sleep, resulting in apneas (complete cessation of airflow for ≥10 seconds) and/or hypopneas (partial reduction of airflow ≥30% for ≥10 seconds with associated oxygen desaturation ≥3-4% or arousal), causing sleep fragmentation, nocturnal hypoxemia, and excessive daytime somnolence.

1. AHI ≥ 5 obstructive respiratory events/hour plus symptoms (EDS, gasping/choking, witnessed apneas, loud snoring) or comorbidities (hypertension, mood disorder, cognitive dysfunction, coronary artery disease, stroke, congestive heart failure, atrial fibrillation, or type 2 diabetes) OR
2. AHI ≥ 15 obstructive respiratory events/hour regardless of symptoms or comorbidities

• Cummings Otolaryngology Head and Neck Surgery, Chapter 15, p. 305

IMPORTANT DEFINITIONS TO KNOW

Severity Classification:

EPIDEMIOLOGY

• OSA is common - affects approximately 2-4% of middle-aged women and 4-9% of middle-aged men in the general population (based on classic Wisconsin Sleep Cohort data)
• Prevalence increases with age and obesity
• Men are affected more than women (roughly 2:1), but the gap narrows after menopause
• Significant underdiagnosis in the general population

• Obesity (BMI ≥30) - most important modifiable risk factor
• Male sex
• Age (middle-aged and older adults)
• Craniofacial abnormalities (retrognathia, micrognathia)
• Large neck circumference (>40 cm in women, >43 cm in men)
• Adenotonsillar hypertrophy (especially in children)
• Nasal obstruction
• Alcohol and sedative use
• Supine sleeping position
• Family history
• Down syndrome, acromegaly, hypothyroidism

PATHOPHYSIOLOGY

The Core Problem

Four Key Phenotypes / Contributing Traits (Cummings ENT, p. 306)

• Most patients have OSA because of anatomical narrowing
• Obesity increases fat deposits in the parapharyngeal spaces around the neck, physically compressing the airway from outside
• Soft tissue hypertrophy: enlarged tonsils, large tongue (macroglossia), elongated soft palate/uvula, retrognathia
• Increased extraluminal pressure collapses the lumen inward

• Normally, when the airway begins to close, mild hypoxia or increased CO2 wakes the brain briefly, restoring airway tone
• In some patients, this threshold is too low - they wake up very easily even before the airway fully closes, causing fragmented sleep
• In others, it is too high - the airway stays closed for longer before an arousal occurs

• The genioglossus (tongue muscle) and other pharyngeal dilator muscles normally increase their activity during sleep to compensate for gravity and muscle relaxation
• In OSA patients, this compensatory response is blunted or delayed - the dilators fail to activate sufficiently, allowing collapse

• "Loop gain" describes how strongly the respiratory control system reacts to changes in blood CO2/O2
• High loop gain = oversensitive control system
• When an apnea causes CO2 to rise, the brain overcorrects by driving breathing too forcefully, which causes CO2 to drop below normal, which then reduces breathing drive again - creating a cycle of alternating under- and over-breathing (Cheyne-Stokes-like pattern worsening apneas)

Anatomical Sites of Obstruction - Fujita Classification (Cummings ENT)

• 100% of OSA patients have retropalatal obstruction (vs. 70% of snorers)
• 77% of OSA patients have retrolingual obstruction (vs. 40% of snorers)
• 76% have multilevel obstruction - the most common scenario
• Laryngeal obstruction (laryngomalacia, bilateral vocal cord palsy) can also rarely cause OSA

Role of Nasal Obstruction

• Nasal obstruction is rarely the sole cause of OSA but worsens it
• It increases airway resistance, promotes mouth breathing during sleep, which reduces the effectiveness of dilator muscles and increases collapsibility
• Snoring can result from nasal obstruction
• Treating nasal obstruction improves snoring and may reduce required CPAP pressure, but rarely cures OSA alone

CLINICAL FEATURES

Nocturnal (Nighttime) Symptoms:

• Loud snoring - most common presenting complaint, often noted by partner
• Witnessed apneas - bed partner notices breathing stops
• Gasping, choking, breath-holding during sleep
• Restless, fragmented sleep
• Nocturia (getting up to urinate)
• Nocturnal sweating
• Bruxism (teeth grinding)
• Nocturnal headaches

Daytime Symptoms:

• Excessive daytime sleepiness (EDS) - cardinal symptom
• Waking unrefreshed regardless of sleep duration
• Morning headache and dry/sore throat
• Memory difficulties, poor concentration
• Cognitive impairment
• Depression, anxiety, mood changes
• Personality changes, irritability
• Decreased libido and impotence
• Morning fatigue

COMORBIDITIES AND CONSEQUENCES

Cardiovascular:

• Systemic hypertension - most well-established consequence (intermittent hypoxia activates sympathetic nervous system)
• Coronary artery disease
• Heart failure
• Atrial fibrillation (leading cause of treatment-resistant AF)
• Stroke
• Pulmonary hypertension

Metabolic:

• Type 2 diabetes mellitus (insulin resistance from hypoxia and sleep disruption)
• Obesity (bidirectional relationship)
• Metabolic syndrome

Neurological/Cognitive:

• Neurocognitive dysfunction
• Increased road traffic accident risk (impaired driving from sleepiness)
• Depression

Other:

• GERD (gastroesophageal reflux)
• Erectile dysfunction
• Increased perioperative risk

DIAGNOSIS

Step 1 - Clinical Screening Tools

• Snoring, Tiredness, Observed apneas, blood Pressure
• BMI >35, Age >50, Neck >40cm, male Gender
• Score ≥3 = high risk for OSA

Step 2 - Physical Examination (ENT Focus)

• Neck circumference (>40 cm women, >43 cm men - significant risk)
• Mallampati score (tongue size relative to oropharynx opening): higher Mallampati = more tongue crowding = more risk
• Tonsil size (Friedman staging system)
• Nasal examination: Deviated septum, turbinate hypertrophy, nasal polyps
• Fiberoptic nasopharyngoscopy: Examines the entire upper airway - nasal cavity, nasopharynx, oropharynx (soft palate, tonsils, lateral walls), hypopharynx (tongue base, epiglottis), and larynx
• Müller maneuver: Patient attempts forceful inspiration against closed nostrils and mouth while surgeon views through fiberoptic scope - reveals retropalatal and retrolingual collapse. Useful mainly for detecting isolated retropalatal collapse; less reliable for multilevel obstruction.

Step 3 - Objective Sleep Study

• Electroencephalogram (EEG) - brain waves, sleep stages
• Electrooculogram (EOG) - eye movements
• Submental EMG - chin muscle tone (REM detection)
• Anterior tibial EMG - leg movements
• Electrocardiogram (ECG)
• Nasal and oral airflow (thermistor + nasal pressure transducer)
• Chest and abdominal respiratory effort (inductance plethysmography)
• Pulse oximetry (SaO2)
• Body position monitor
• Tracheal microphone (snoring)

• Portable, simpler recording device
• Suitable for uncomplicated adults with signs/symptoms suggesting moderate-to-severe OSA
• Limitation: High false negative rate (tends to underestimate AHI because it records time in bed, not actual sleep time)
• If HSAT is negative or inconclusive - proceed to full in-lab PSG

• Type I: Full in-lab PSG with technologist
• Type II: Full portable unattended PSG
• Type III: Modified portable (airflow + effort + oximetry - no EEG)
• Type IV: Single/dual bioparameter (oximetry only)

Step 4 - Advanced Imaging/Endoscopy for Surgical Planning

• Fiberoptic nasopharyngoscopy performed under pharmacologic sedation (propofol ± midazolam)
• Simulates natural sleep to observe dynamic airway collapse
• More accurate than awake examination - poor correlation between awake and sedated endoscopic findings
• A 2024 systematic review (Di Bari et al., PMID: 37851322, Sleep & Breathing) of 880 patients showed DISE group had significantly better ODI reduction (-19.6 vs. -12.6, p<0.001), ESS improvement (-6.72 vs. -3.69, p<0.001), and better LOS improvement. Surgical success rate was significantly higher with DISE vs. Müller Maneuver (64% vs. 52%, p=0.016).
• Changed surgical plan in >50% of cases in prior meta-analyses
• VOTE Classification used to record findings: Velum, Oropharynx, Tongue base, Epiglottis

TREATMENT

CONSERVATIVE / NON-SURGICAL TREATMENT

1. Weight loss: Most important. Even 10% weight reduction can significantly reduce AHI. Weight loss combined with CPAP is more effective than either alone.
2. Positional therapy: Sleeping on the side (lateral position) instead of supine. The tongue and soft palate fall backward in the supine position due to gravity, collapsing the airway. Tennis ball technique (sewing a tennis ball into the back of a sleep shirt to prevent supine sleep) or positional sleep devices are used. Most effective for positional OSA (AHI at least twice as high when supine vs. lateral).
3. Avoid alcohol: Alcohol relaxes pharyngeal muscles and raises arousal threshold - worsening apneas. Avoid within 4-6 hours of sleep.
4. Avoid sedatives and hypnotics: Same mechanism as alcohol.
5. Smoking cessation: Causes upper airway inflammation and mucosal edema.
6. Sleep hygiene: Regular sleep schedule, adequate sleep duration.
7. Treat underlying conditions: Hypothyroidism, acromegaly if present.

• CPAP (fixed pressure): One constant pressure throughout the night. Standard first choice.
• APAP (Auto-titrating PAP): Automatically adjusts pressure throughout the night in response to snoring, flow limitation, and apneas. More comfortable as pressure is only high when needed.
• BiPAP (Bilevel PAP - IPAP/EPAP): Different pressures for inhalation and exhalation. Used for severe OSA, obesity hypoventilation syndrome, central sleep apnea, or when patients cannot tolerate CPAP exhalation pressure.

• In-lab titration study: PSG while CPAP pressure is manually adjusted by technologist to find the minimum pressure that eliminates apneas
• Split-night study: First half diagnostic, second half titration (if AHI >40 in first 2 hours)
• Auto-PAP: Can serve as both a titration and long-term therapy device

• Custom-fitted dental device worn during sleep
• Advances the mandible (lower jaw) forward by 5-10 mm, which pulls the tongue and soft palate forward, enlarging the pharyngeal airway
• Effective for mild to moderate OSA and patients who cannot tolerate CPAP
• Adherence rates up to 77% (higher than CPAP)
• Ferguson et al. crossover study: effective for AHI 15-50, higher patient satisfaction than CPAP - but CPAP reduces AHI more effectively
• European Respiratory Society (ERS): recommends as second-line therapy for mild-moderate OSA and for CPAP-intolerant patients
• Requires a follow-up PSG with the device in place to confirm effectiveness
• Complications: jaw/tooth pain, difficulty chewing in the morning, excessive salivation, TMJ discomfort, dental changes with long-term use

• Nasal dilator strips (e.g., Breathe Right): Reduce snoring and mouth breathing. Do NOT effectively treat OSA as standalone therapy.
• Intranasal corticosteroids (e.g., fluticasone): Useful when OSA coexists with allergic rhinitis. Fluticasone reduced AHI from 30.3 to 23.3 in one study. Recommended for pediatric OSA with adenotonsillar hypertrophy. Not recommended as standalone adult OSA treatment.
• Montelukast (leukotriene receptor antagonist): Shown to reduce adenoid size and improve mild OSA in children.
• Nasal decongestants + oxymetazoline: Reduce nasal obstruction acutely; reduce mouth breathing and OSA severity but do not cure OSA.

• Modafinil: FDA-approved only for residual daytime sleepiness in CPAP-compliant OSA patients who still have EDS. Central stimulant (postsynaptic α1-adrenergic). Must NOT be used instead of CPAP.
• Protriptyline, fluoxetine, acetazolamide, and others have been studied but insufficient evidence for routine use.
• None of the currently available drugs adequately treat the underlying airway obstruction.

SURGICAL TREATMENT

• AHI ≥5 and ≤14 with symptoms or comorbidities
• AHI ≥15
• Oxyhemoglobin desaturation <90%
• UARS with objective neurocognitive dysfunction
• Significant cardiac arrhythmias associated with obstructions
• Unsuccessful or refused medical therapy
• Medically stable to undergo surgery

• Determine the level(s) of obstruction using DISE before choosing surgery
• Most patients have multilevel obstruction - may need multilevel surgery
• Staged surgical protocol is standard - not everything at once
• Anesthesia planning is critical: avoid paralytics until patient can be mask-ventilated; have alternative airway plan ready; discuss tracheotomy possibility with patient

A. NASAL SURGERY

• Septoplasty: Corrects deviated nasal septum
• Inferior turbinate reduction (surgical, radiofrequency, or laser): Reduces turbinate bulk
• Functional Endoscopic Sinus Surgery (FESS): When sinonasal disease contributes
• Nasal valve repair

B. PALATAL / OROPHARYNGEAL SURGERY

• Classic ENT surgery for OSA
• Removes the uvula, posterior soft palate, and redundant lateral pharyngeal wall tissue; tonsillectomy if tonsils present
• Enlarges the retropalatal airway
• Success rate ~40-60% (defined as AHI reduction >50% and AHI <20)
• Better results in patients with isolated retropalatal obstruction (Type I Fujita) and lower AHI
• Limited effectiveness in multilevel obstruction
• Complications: VPI (velopharyngeal insufficiency - nasal regurgitation), dysphonia, swallowing difficulty, nasopharyngeal stenosis, recurrence

• Performed under local anesthesia in office
• Multiple sessions
• Less tissue removed than UPPP
• Effective for snoring but not recommended as sole treatment for OSA - may actually mask symptoms while OSA continues

• Three braided polyester implants injected into the soft palate
• Stiffens the soft palate, reducing vibration (snoring) and collapse
• Minimally invasive, done under local anesthesia
• Most effective for mild OSA with isolated soft palate vibration

• Low-energy radiofrequency energy applied to soft palate or tongue base
• Creates submucosal scar tissue that contracts and stiffens the tissue
• Multiple sessions required
• Minimal discomfort, done in office under local anesthesia
• Reduces palatal volume and tongue base volume
• Less effective than UPPP but lower morbidity

• Advances the hard palate anteriorly to widen the retropalatal space
• Used in patients with severe retropalatal narrowing

• Technique that repositions the palatopharyngeus muscle laterally and superiorly
• Increases lateral pharyngeal wall tension, preventing lateral wall collapse
• Better than UPPP for lateral wall collapse pattern on DISE

C. TONGUE BASE / HYPOPHARYNGEAL SURGERY

• A rectangular section of mandible at the level of the geniotubercle is cut and advanced 8-10 mm forward, then rotated 90° to lock it in place
• This pulls the genioglossus muscle (tongue root's primary attachment) forward, tensioning the tongue base and preventing its backward collapse
• Usually combined with UPPP (Phase I surgery)
• Success rate ~60-70% when combined with UPPP for multilevel obstruction

• The hyoid bone is surgically moved forward and anchored to the mandible (or thyroid cartilage)
• The hyoid is the attachment point for tongue base and epiglottis muscles
• Pulling it forward expands the hypopharyngeal airway
• Used as adjunct with genioglossus advancement

• Coblation channeling: radiofrequency channels placed into tongue base tissue to reduce bulk
• Laser midline glossectomy: removes midline tongue base tissue
• Robotic tongue base resection (TORS - see below)
• All aim to reduce tongue base volume and decrease retrolingual collapse

• Via an intraoral incision in the frenulum, a titanium screw placed on the mandible anchors a permanent suture through the tongue musculature pulling the tongue base anteriorly
• Success rates 20-57% with UPPP; one study showed 78% at 3 years for severe OSA refusing CPAP
• Not recommended as single treatment in obese patients with moderate-severe OSA

• When DISE shows epiglottic collapse as contributor
• Epiglottis is surgically stiffened or repositioned
• Increasingly performed as part of multilevel sleep surgery

D. MAXILLOMANDIBULAR ADVANCEMENT (MMA) - Major Surgery

• The most effective surgery for OSA overall
• Technique: Le Fort I maxillary osteotomy + bilateral sagittal split mandibular osteotomy; both jaws advanced at least 10 mm
• Enlarges both the retropalatal and retrolingual airways simultaneously
• Usually performed after other surgery has failed
• Meta-analysis demonstrates mean AHI reduction of 44.8 events/hour with >80% mean AHI improvement - the highest of any surgical procedure
• Complications: malocclusion, relapse, nerve paresthesia (inferior alveolar nerve), non-union, TMJ problems, infection, bleeding, need for dental work
• Cummings Otolaryngology, p. 318

E. TRANSORAL ROBOTIC SURGERY (TORS) for OSA

• Robot-assisted surgery (da Vinci system) for precise tongue base resection and epiglottectomy/epiglottopexy
• Advantage over coblation: precise tissue removal in a deep, narrow space
• A multiinstitutional study (2015): 293 procedures in 285 patients - mean AHI decrease of 24, overall success rate (AHI <20 with 50% reduction) achieved as part of multilevel sleep surgery; complication rate 20.7% but no life-threatening events
• Systematic review of 16 studies: results promising especially when BMI <30
• Gaining acceptance for tongue base-predominant OSA
• Cummings Otolaryngology, pp. 314-315

F. TRACHEOTOMY

• The oldest and most effective surgical treatment for OSA - virtually 100% effective as it completely bypasses the upper airway
• Reserved for:
  • Life-threatening severe OSA with cardiac arrhythmias
  • All other treatments failed or contraindicated
  • Morbid obesity with severe disease
  • Pre-operatively as airway protection for complex sleep surgery
• Not a long-term first-choice due to major impact on quality of life

RECENT AND EMERGING TREATMENT MODALITIES

1. Hypoglossal Nerve Stimulation (HNS) - Inspire Therapy

• A device (Inspire system - FDA approved 2014) is implanted subcutaneously
• A sensing lead around the intercostal muscles detects each breath
• A stimulating lead wraps around the hypoglossal nerve (CN XII - controls tongue movement)
• During sleep, the device senses inspiration and delivers a gentle electrical pulse to the hypoglossal nerve, causing the genioglossus muscle to contract, moving the tongue forward and opening the airway
• Patient activates via a small hand-held remote before sleeping

• Moderate-to-severe OSA (AHI 15-65)
• Failed or cannot tolerate CPAP
• BMI <35 (generally)
• No complete concentric collapse (CCC) of the palate on DISE - must have predominantly tongue-base/hypopharyngeal collapse
• No significant central sleep apnea

• 2024 Meta-Analysis (Kim et al., PMID: 38123511, Otolaryngology-HNS): 44 studies, 8,670 patients. At 12 months: 47% achieved AHI <5, 72% achieved AHI <10, 82% achieved AHI <15. Clinical success rate (Sher criteria: AHI <20 with 50% reduction) = 80% at 12 months, 73% at 12-36 months. Effects sustained consistently between 12 and 36 months.
• 2024 Systematic Review + Meta-Analysis (Kim et al., PMID: 37661785, Journal of Sleep Research): 10 studies, 2,209 patients. HNS vs. other airway surgeries (UPPP, expansion sphincter pharyngoplasty, tongue base surgery): HNS had significantly lower postoperative AHI (MD -8.00, 95% CI -12.03 to -3.97). Rates of post-treatment AHI <10 and <15 were significantly better in HNS group. Conclusion: HNS is superior to conventional airway surgery for selected CPAP-intolerant moderate-severe OSA patients.
• 2024 Updated Meta-Analysis (Alrubasy et al., PMID: 39401661, Respiratory Medicine): 30 papers. Inspire device reduced AHI by 20.14 events/hour short-term and 15.91 events/hour long-term. ODI reduced by 14.16 (short-term). ESS score improved by 5.02 points. FOSQ (functional outcomes of sleep quality of life score) improved by 3.58. High adherence and satisfaction rates.

• Inspire (Inspire Medical Systems) - most studied, FDA approved
• Apnex - similar concept, slightly less improvement
• ImThera (Genio system) - stimulates multiple branches of hypoglossal nerve simultaneously

2. Drug-Induced Sleep Endoscopy (DISE) - Advanced Diagnostic Tool

3. Positional Therapy Devices (New Generation)

• Traditional tennis ball technique is poorly tolerated
• New wearable devices (e.g., Night Shift, NightBalance) worn on chest or back
• Vibrate gently when patient rolls to supine position, prompting lateral repositioning without fully waking them
• Effective for positional OSA (significantly more apneas when supine)
• Good adherence compared to older positional methods

4. Myofunctional Therapy (Oropharyngeal Exercises)

• Structured exercises targeting the tongue, soft palate, pharynx, and facial muscles
• Strengthen upper airway dilators, reduce collapsibility
• Systematic reviews show AHI reduction of ~50% and significant reduction in snoring
• Safe, non-invasive, no side effects
• Best evidence in mild-moderate OSA
• Used as adjunct or in patients refusing other therapies

5. Bariatric Surgery for OSA

• In morbidly obese patients with OSA, bariatric surgery (gastric bypass, sleeve gastrectomy) produces substantial weight loss that dramatically reduces AHI
• Some patients achieve complete resolution of OSA post-bariatric surgery
• Not a targeted OSA treatment but highly effective through weight reduction

6. Pharmacotherapy in Development

• AD109 (aroxybutynin + atomoxetine): Combination that increases upper airway muscle tone and raises arousal threshold. Phase II trials showed significant AHI reduction. Under ongoing investigation.
• Cannabinoids (dronabinol): Reduces REM sleep (when most apneas occur) and increases serotonin-mediated muscle tone. Mixed evidence currently.

SUMMARY TABLE - Treatment Algorithm

PERIOPERATIVE CONSIDERATIONS

• More difficult airway (increased Mallampati, pharyngeal edema, narrow airway)
• Opioids cause respiratory depression and worsen upper airway collapse - minimize opioid use; prefer regional anesthesia when possible
• Postoperative monitoring: CPAP must be continued in the perioperative period
• Extubation only when fully awake and protective airway reflexes are intact
• Prefer semi-upright position in recovery
• Avoid sedatives and benzodiazepines

Sources

• Kim et al. 2024 - HNS effects over time: meta-analysis of 8,670 patients (Otolaryngology-HNS, PMID: 38123511)
• Kim et al. 2024 - HNS vs. alternative surgeries: comparative meta-analysis (Journal of Sleep Research, PMID: 37661785)
• Alrubasy et al. 2024 - Updated HNS meta-analysis: Inspire, Apnex, ImThera devices (Respiratory Medicine, PMID: 39401661)
• Di Bari et al. 2024 - DISE effect on surgical outcomes: 880 patients (Sleep & Breathing, PMID: 37851322)
• Habetha et al. 2024 - 10 years of hypoglossal nerve stimulation: systematic review (Pneumologie, PMID: 38914119)